Ketamine-related harm is strongly linked to repeated and frequent exposure. The clearest longer-term concerns include bladder and urinary damage, recurrent abdominal pain, liver and bile-duct complications, dependence and cognitive effects. Early symptoms such as urinary urgency, blood in the urine, persistent abdominal pain or difficulty cutting down should not be ignored, because some complications may become harder to reverse if they progress.
Ketamine can be used safely in medical settings, but the risk changes when use becomes frequent, unsupervised or involves a substance of uncertain origin.
The main concerns are not limited to short-term intoxication. Repeated use can affect the bladder and urinary tract, cause severe abdominal pain, contribute to liver and bile-duct problems, and lead to dependence. Some of these complications can become difficult to reverse if they are ignored for too long.
Risk is not identical for everyone. Frequency of use, overall exposure, other substances, underlying health conditions and whether the product is medically regulated all matter. That is why it is more useful to understand the pattern of harm than to treat ketamine as either harmless or uniformly dangerous.
The UK Advisory Council on the Misuse of Drugs reviewed the evidence again in 2026 and found increasing concern around frequent use, dependence and serious urinary and hepatobiliary complications. See the ACMD’s updated review of ketamine use and harms.
Ketamine safety at a glance
| Area of concern | What can happen |
|---|---|
| Short-term effects | Dissociation, impaired coordination, reduced awareness, agitation, hallucinations and sedation |
| Bladder and urinary tract | Urgency, frequent urination, pain, blood in the urine, reduced bladder capacity and longer-term urinary damage |
| Abdomen | Severe recurrent abdominal pain, sometimes referred to as K-cramps |
| Liver and bile ducts | Abnormal liver function, cholestatic injury and bile-duct abnormalities in some frequent users |
| Dependence | Tolerance, difficulty cutting down, continued use despite harm and withdrawal symptoms after heavy use |
| Unknown products | Uncertainty about identity, concentration, contaminants and adulteration |
What are the short-term risks of ketamine?
Short-term ketamine effects can include dissociation, impaired coordination, hallucinations, agitation, abnormal movements and reduced consciousness.
The ACMD review also describes more serious acute effects such as significant changes in pulse or blood pressure, prolonged sedation, respiratory depression and convulsions.
The practical risk is not just what the drug does internally. Someone who is confused or heavily dissociated may be less able to recognise traffic, water, stairs, heights or other immediate hazards.
That loss of situational awareness can matter even when the person does not feel physically unwell.
Why does ketamine affect the bladder?
Ketamine and its metabolites can damage the lining of the urinary tract.
The ACMD describes toxic effects on urothelial cells, the cells that line parts of the urinary system. With repeated exposure, this can lead to inflammation, pain and structural changes in the bladder.
Over time, the bladder can lose capacity and become increasingly painful. In severe cases, damage can extend further up the urinary tract and affect the kidneys.
This is one of the clearest examples of why frequency matters. A person may initially notice only mild urgency or an increase in how often they need to urinate, while ongoing exposure can allow the problem to progress.
What are the warning signs of ketamine-related bladder damage?
Common symptoms include needing to pass urine much more often, waking at night to urinate, sudden urgency, leakage, burning or pain when urinating, blood in the urine and bladder pain.
The ACMD reports that about a quarter of people who use ketamine regularly experience at least one urinary symptom, with risk increasing alongside frequency and exposure.
These symptoms should not automatically be dismissed as a routine urinary infection, particularly when they keep returning.
Persistent urinary pain, blood in the urine or a marked change in urinary frequency deserves medical assessment.
Can ketamine bladder damage become permanent?
Some ketamine-related urinary changes can improve when exposure stops, but recovery is not guaranteed.
The ACMD warns that urinary damage may only partially resolve in some people and can become irreversible when it has progressed far enough.
This is why early symptoms matter. Waiting until bladder pain or urinary frequency becomes severe can mean waiting until the condition is considerably harder to manage.
The most important part of treatment for ketamine-induced uropathy is stopping ketamine exposure, although some people also require medicines, bladder treatments or surgery. Specialist care may be needed in more severe cases.
What are K-cramps?
“K-cramps” is an informal name for severe abdominal pain associated with repeated ketamine use.
The term sounds casual, but the underlying problem should not be treated casually. Episodes can involve intense abdominal pain and may also include vomiting.
The ACMD’s 2026 review reports that chronic abdominal pain affects more than a quarter of regular users in the evidence it considered.
There is no single explanation for every episode of abdominal pain in someone who uses ketamine, which is another reason recurrent or severe symptoms should be medically assessed rather than simply labelled as K-cramps.
Can ketamine affect the liver and bile ducts?
Yes. Repeated ketamine exposure has been associated with abnormal liver tests and problems affecting the biliary system.
The ACMD describes cholestatic liver injury and chronic widening of the bile ducts in some people who use ketamine regularly. Its review cites evidence suggesting biliary abnormalities in roughly 10% of regular users in some studied groups.
These complications receive less public attention than bladder damage, so they may be easier to overlook.
Persistent upper abdominal pain, jaundice or abnormal liver tests need proper medical assessment rather than an assumption that they are simply part of ketamine use.
Can ketamine cause dependence?
Yes. Ketamine can become habit-forming, particularly when use becomes frequent or heavy.
Dependence often develops gradually. Someone may start using occasionally, find that the same amount no longer produces the same effect, and begin using more often or in greater amounts.
The ACMD reports increasing recognition of ketamine use disorder among people who regularly consume high amounts. It also notes that withdrawal symptoms can occur when heavy use stops.
Possible signs of dependence include:
- using more often than intended
- finding it difficult to cut down
- needing more to achieve the same effect
- continuing despite bladder, abdominal or other health problems
- spending increasing amounts of time obtaining, using or recovering from ketamine
- feeling unable to function normally without it
Dependence is a reason to seek help, not a reason to wait until the situation becomes more severe.
What does ketamine withdrawal look like?
Withdrawal from heavy ketamine use can occur, although the evidence base is less developed than it is for substances such as alcohol or opioids.
The ACMD notes that symptoms may persist for several days after heavy use stops, but also highlights that evidence on the best way to manage ketamine withdrawal remains limited.
That uncertainty is another reason people who feel dependent should speak with a GP or drug treatment service rather than trying to interpret every symptom themselves.
The NHS advises that people who want help with a drug problem can speak with a GP or contact a local drug treatment service directly. Treatment is available through NHS and charitable services. See NHS guidance on getting help for drug addiction.
What about memory, thinking and mental health?
Frequent ketamine use may affect memory, attention and other aspects of cognitive function, although the evidence is not equally strong for every claimed effect.
One problem with long-term observational research is that people may also be using other substances or living with sleep disruption, anxiety, depression or other factors that affect cognition.
The ACMD nevertheless concludes that chronic, frequent or high-level illicit ketamine use may impair cognitive functioning and affect neural circuits. Some effects may improve after use stops, but that does not mean every effect is necessarily reversible.
The useful position here is neither alarmist nor dismissive: repeated heavy use appears to carry cognitive risk, even if the exact degree varies between people.
Does mixing ketamine with other substances increase risk?
Yes. Combining ketamine with other substances can make the effects less predictable and may increase the risk of serious impairment.
Particular concern applies when ketamine is combined with substances that also depress the central nervous system, because sedation and loss of consciousness may become more significant.
Alcohol, opioids and benzodiazepines can all add to impairment. Stimulants create a different pattern of risk, including additional cardiovascular strain and more unpredictable behavioural effects.
The important point is that drug combinations do not simply “add” one set of effects to another. They can alter how severe or noticeable those effects become.
This site will cover individual interactions separately so that each one can be discussed with the level of detail it deserves rather than reduced to a generic warning.
Why are unregulated products harder to assess?
When ketamine is used in a regulated medical setting, clinicians know what medicine they are administering and what concentration it contains.
An unregulated product does not automatically come with that certainty.
The seller may describe a product as pure, pharmaceutical grade or laboratory tested, but those claims do not independently prove the identity or composition of the material supplied.
This is why appearance cannot be treated as a substitute for verification. Powder, crystals, liquid or informal descriptions such as “rock” and “raw” say little on their own about chemical identity.
See our Forms of Ketamine guide for a fuller explanation of the terminology.
Medical ketamine and non-medical use carry different risks
It is misleading to talk about ketamine safety without considering context.
| Medically supervised ketamine | Unregulated use |
|---|---|
| Known pharmaceutical product | Product identity may be uncertain |
| Known concentration | Strength may not be independently verified |
| Patient assessed beforehand | No automatic health assessment |
| Monitoring available | No clinical monitoring |
| Use based on a medical indication | Pattern and frequency may be uncontrolled |
| Adverse effects can be recognised and managed | Complications may go unnoticed or untreated |
That does not make medical ketamine free from side effects. It means the risks are assessed and managed within a healthcare system.
For more detail, see Medical Ketamine: Treatment, Uses and UK Access.
What does harm reduction mean in this context?
Harm reduction means taking health concerns seriously before they become emergencies.
It does not mean pretending that repeated ketamine use is harmless, nor does it require moral judgement. The practical aim is to reduce preventable injury, recognise warning signs earlier and make it easier for someone to seek help.
For ketamine, that means paying attention to persistent urinary symptoms, abdominal pain, increasing tolerance, difficulty reducing use and any pattern in which use is becoming more frequent or harder to control.
It also means recognising that an unknown product cannot be assumed to be safer because of its colour, crystal size, packaging or marketing description.
When should someone seek urgent medical help?
Call 999 for a life-threatening emergency.
Urgent warning signs include loss of consciousness, severe difficulty breathing, seizures or any situation in which someone is seriously unwell after taking a substance. NHS guidance advises calling 999 or going to A&E for serious poisoning symptoms such as unconsciousness, stopped or severely impaired breathing, or a seizure. See NHS guidance on poisoning.
If the situation is urgent but you are unsure whether it is an emergency, NHS 111 can advise on the appropriate next step.
When should someone speak to a GP?
A person does not need to wait for an emergency before asking for medical help.
Repeated urinary urgency, pain when passing urine, blood in the urine, persistent bladder pain, recurrent abdominal pain or concern about dependence are all reasonable reasons to speak with a healthcare professional.
If drug use itself has become difficult to control, a GP can discuss treatment options and refer someone to a local service. People can also contact local drug treatment services directly.
The NHS also provides a drug treatment service finder.
Can ketamine-related harm improve after stopping?
Some problems can improve after ketamine exposure stops, particularly when they are recognised early.
However, improvement is not guaranteed, and severe urinary or biliary complications may persist. The ACMD specifically warns that some effects may only partly resolve or may become irreversible.
This is one reason early intervention matters more than waiting for a symptom to become unbearable.
What is the most important safety point?
Frequency and persistence of symptoms matter.
A single unpleasant experience and months of escalating use are not the same clinical situation. Recurrent bladder symptoms, repeated abdominal pain, growing tolerance or difficulty stopping are all signs that the pattern of use deserves attention.
The other important distinction is product certainty. A regulated medicine comes with information about what it contains. An unregulated product may not.
Understanding those two issues — pattern of use and certainty about the substance — provides a much more useful picture of risk than simply asking whether ketamine is “safe” or “dangerous”.
References
- Advisory Council on the Misuse of Drugs: Ketamine – an updated review of use and harms
- ACMD: Ketamine – updated review of use and harms, accessible version
- NHS: Drug addiction – getting help
- NHS: Find drug treatment services
- NHS: Poisoning – emergency advice
Evidence last checked: 18 September 2026
